IBN Sina Pharma's Q3 profits up 44%
IBN Sina Pharmaceutical Industry secured a 44 percent year-on-year rise in profit in the January-March period of fiscal year 2023-24, which it attributed to an aggressive marketing strategy and proactive support from the management.